Pfizer develops new COVID Pill


Getty Images

The Pfizer logo is seen at the Pfizer Inc. headquarters on December 9, 2020 in New York City. (Photo by Angela Weiss / AFP) (Photo by ANGELA WEISS/AFP via Getty Images)

   WORLDWIDE – Pfizer has been working on a new pill that could be a home test for COVID-19 that could be ready later this year. The pill is designed to attack the virus’ “spine” to keep it from spreading to the nose, throat, and lungs. According to documents obtained from Pfizer, the company is in the first phase of testing the drug, which includes testing for “significant side effects, and how people feel after taking it.” The pill named “PF-07321332” will be going through many trials with people varying from ages eighteen to sixty. “We have designed PF-07321332 as a potential oral therapy that could be prescribed at the first sign of infection, without requiring that patients are hospitalized or in critical care,” said Mikael Dolsten, who leads Pfizer’s Worldwide Research and Medical Division team.


(Compiled from The New York Post by Ewan Bickford for The Guilford Voyager with original reporting done by Jackie Salo).